Effect of Vandetanib on Andes virus survival in the hamster model of Hantavirus pulmonary syndrome

Published 2016 View Full Article

Authors

Keywords

Bunyaviridae, Andes virus, Hantavirus pulmonary syndrome, Antiviral, Animal model, Hemorrhagic fever, Vascular endothelial growth factor, Vandetanib, Tyrosine kinase inhibitor

Journal

ANTIVIRAL RESEARCH

Volume 132, Issue -, Pages 66-69

Publisher

Elsevier BV

Online

2016-05-25

DOI

10.1016/j.antiviral.2016.05.014

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started